Non-Small Cell Lung Cancer
Drugs (by generic name) associated with Non-Small Cell Lung Cancer
The following drugs and medications are in some way related to, or used in the treatment of Non-Small Cell Lung Cancer.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
amifostine systemic (Pro, More...)
 class: antidotes | 0 Review(s) | Not rated - Be the first
|
bevacizumab systemic (Pro, More...)
class: antineoplastic monoclonal antibodies | 0 Review(s) | Not rated - Be the first
|
cisplatin systemic (Pro, More...)
class: alkylating agents | 0 Review(s) | Not rated - Be the first
|
docetaxel systemic (Pro, More...)
class: mitotic inhibitors | 0 Review(s) | Not rated - Be the first
|
erlotinib systemic (Pro, More...)
class: tyrosine kinase inhibitors | 0 Review(s) | Not rated - Be the first
|
gefitinib systemic (More...)
class: tyrosine kinase inhibitors | 0 Review(s) | Not rated - Be the first
|
gemcitabine systemic (Pro, More...)
class: antimetabolites | 0 Review(s) | Not rated - Be the first
|
paclitaxel systemic (Pro, More...)
class: mitotic inhibitors | 0 Review(s) | Not rated - Be the first
|
pemetrexed systemic (Pro, More...)
class: antimetabolites | 0 Review(s) | Not rated - Be the first
|
porfimer systemic (Pro, More...)
class: miscellaneous antineoplastics | 0 Review(s) | Not rated - Be the first
|
vinorelbine systemic (Pro, More...)
class: mitotic inhibitors | 0 Review(s) | Not rated - Be the first
|
Non-Small Cell Lung Cancer Related Drugs in the Pipeline
Xyotax (paclitaxel poliglumex)
LEP-ETU (Liposome Entrapped Paclitaxel )
Browse drugs by condition:
